American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
about
An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritisShould axial spondyloarthritis without radiographic changes be treated with anti-TNF agents?Early anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitis.Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted BiologicsThe Efficacy of Imrecoxib and Celecoxib in Axial Spondyloarthritis and Their Influence on Serum Dickopff-Related Protein 1 (DKK-1) LevelsA review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeability.A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis.Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.Indirect comparisons of the efficacy of biological agents in patients with active ankylosing spondylitis: a systematic review and meta-analysis.Biologics Use in Asian Indian Patients with Ankylosing Spondylitis: A Physician's Perspective.Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing Spondylitis.Anti-IL17A in Axial Spondyloarthritis-Where Are We At?Tumor necrosis factor-α (TNFα) inhibitors in the treatment of nonradiographic axial spondyloarthritis: current evidence and place in therapy.Osteoporosis Management in Ankylosing Spondylitis.Secukinumab (AIN457) in the treatment of ankylosing spondylitis.The Bench-to-Bedside Story of IL-17 and the Therapeutic Efficacy of its Targeting in Spondyloarthritis.Physical activity in axial spondyloarthritis-tails from bench to bedside.Targeting the interleukin-23/17 axis in axial spondyloarthritis.HLA-B27 Anterior Uveitis: Immunology and Immunopathology.Secukinumab: A Review in Ankylosing Spondylitis.Certolizumab pegol for treating axial spondyloarthritis.Infliximab Biosimilar (CT-P13; Infliximab-dyyb): A Review in Autoimmune Inflammatory Diseases.Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.Treat to Target in Axial Spondyloarthritis: What Are the Issues?Fever as an initial manifestation of spondyloarthritis: A retrospective study.Management of patients with inflammatory bowel disease and spondyloarthritis.Rituximab Can Induce Remission in a Patient with Ankylosing Spondylitis Who Failed Anti-TNF-α Agent.Gene Expression Analysis before and after Treatment with Adalimumab in Patients with Ankylosing Spondylitis Identifies Molecular Pathways Associated with Response to Therapy.Patient Burden of Axial Spondyloarthritis.Rare occurrence of inflammatory bowel disease in a cohort of Han Chinese ankylosing spondylitis patients- a single institute study.Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritisOpioid Analgesic Use in Patients with Ankylosing Spondylitis: An Analysis of the Prospective Study of Outcomes in an Ankylosing Spondylitis Cohort.Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study.Have the annual trends of total knee arthroplasty in ankylosing spondylitis patients decreased?Nonradiographic axial spondyloarthritis: clinical and therapeutic relevance.Validity of Simplified Ankylosing Spondylitis Disease Activity Scores (SASDAS) in Indian Ankylosing Spondylitis Patients.The use of the tyrosine kinase inhibitor Nilotinib in Spondyloarthritis: does targeting inflammatory pathways with a treatment lead to vascular toxicity?Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithm.The clinical importance of the thyroid nodules during anti-tumor necrosis factor therapy in patients with axial spondyloarthritis.The Duality of Economic Issues With Medication Non-adherence in Patients With Inflammatory Arthritis.
P2860
Q26741170-44A8118C-E55F-4BFD-9C54-B9FF7986FAF6Q30239856-F70F5785-BB19-4B57-8E26-36EA600A139FQ33742894-F76F6DED-7B6C-44A5-BD63-7AC2D7069FF4Q33809045-C2C9F484-DD76-4530-922A-D9467E25B043Q33841187-0B4145F2-B561-4C0D-BC03-5E665DB22D0BQ33881234-2546340A-C73A-4320-91BE-5CCCA71BB422Q36163165-264C08F3-47C6-4AF1-BBE0-89F49C1D0D65Q36287340-A88185CA-4ECC-4177-B433-04A58FDC5ECFQ36383550-0EF686FB-0469-4010-AC45-0C0CA7E8F524Q37250836-0318501B-99A3-426E-BC6C-845514AF6A83Q37453012-AE174FE3-73D9-4596-AE76-65097BF16E46Q37590576-0A5F15C8-637B-4D0B-828C-D5362D121332Q38611064-B880F47F-FFC8-4785-B02A-4004BB5931B8Q38670399-0D445F87-824D-4032-908F-355BFFE058E6Q38777116-75FC85A5-8983-4682-A8BE-206A7351A724Q38815070-05416382-2455-4BCA-86D9-F1247748E901Q38818601-19262157-B9D7-4E19-BE71-06051574A78CQ38827500-BB2FDA40-E613-4278-AD33-872811AB2FECQ38849274-9BDE8DC3-3B00-4F72-A1B4-1CE6520DDA41Q38851890-8B0DA597-48FE-4850-8599-329E26FDFF14Q38883124-E99A2B8D-E383-4979-B475-E993F52C621BQ38960108-AD74F14B-87E8-413C-A291-1E79B3B34E79Q39135959-98D906F6-9FCC-46EB-A1F6-66EBF7105CBDQ39225782-BED56D5D-B0EF-42F2-8D7D-DF218A32CAAAQ40038890-7F3777C7-E20E-467F-AA6A-857B641DF140Q40054186-992BFF28-4797-4371-A7DE-90F55C3D4977Q41895311-ACB4103F-5737-45A7-AA19-6F3788B310B3Q42081086-5E449643-3964-409A-BCD2-F350A4C7C9F1Q42365374-21976C0D-962A-45F2-B5C2-5D0471BD3F65Q42377151-2E65C004-F878-49B3-9988-A7FAAC72F607Q42682318-BDB325E0-139E-464F-93A3-9F0F5450D8B3Q46052645-F935EA30-D0D4-49B5-A4BE-7997EC0873F1Q47100492-85A112A1-BB90-43BB-94B8-8B5329A321A1Q47104824-C4E3DC77-AEDB-4467-8342-24F1C68FFD72Q47105493-E372777A-F218-4543-B932-AC1D34635E89Q47110014-D509978A-ECAD-44BC-9557-3D832FC7831AQ47159332-FE9B1E63-A5A6-4B26-8146-A371C2123946Q47688424-6765D203-A121-4AFB-B86D-1413E40047D5Q47810787-B92E13AC-C1A9-46D3-84ED-7D217573B967Q47943997-1A07F5CD-29B6-4594-8421-995998E9D597
P2860
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
American College of Rheumatolo ...... aphic Axial Spondyloarthritis.
@ast
American College of Rheumatolo ...... aphic Axial Spondyloarthritis.
@en
type
label
American College of Rheumatolo ...... aphic Axial Spondyloarthritis.
@ast
American College of Rheumatolo ...... aphic Axial Spondyloarthritis.
@en
prefLabel
American College of Rheumatolo ...... aphic Axial Spondyloarthritis.
@ast
American College of Rheumatolo ...... aphic Axial Spondyloarthritis.
@en
P2093
P2860
P50
P356
P1476
American College of Rheumatolo ...... aphic Axial Spondyloarthritis.
@en
P2093
Amy S Miller
Andrew Lui
Atul Deodhar
Bruce M Clark
David Borenstein
David S Hallegua
David T Y Yu
Elie A Akl
Filip van den Bosch
James T Rosenbaum
P2860
P304
P356
10.1002/ART.39298
P577
2015-09-24T00:00:00Z